Krystal Biotech buy The Goldman Sachs Group, Inc.
Start price
30.01.26
/
50%
€237.90
Target price
30.01.27
-
Performance (%)
-1.98%
Price
17.04.26
€233.20
Summary
This prediction is currently active. With a performance of -1.98%, the BUY prediction by The_Goldman_Sachs_Gr is trending in the wrong direction. This prediction currently runs until 30.01.27. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Krystal Biotech | 5.520% | 5.520% |
| iShares Core DAX® | 3.593% | 3.931% |
| iShares Nasdaq 100 | 5.810% | 5.518% |
| iShares Nikkei 225® | 4.075% | 8.460% |
| iShares S&P 500 | 4.142% | 4.039% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Krystal Biotech diskutieren
Krystal Biotech (NASDAQ:KRYS) had its "buy" rating reaffirmed by analysts at The Goldman Sachs Group, Inc..
Ratings data for KRYS provided by MarketBeat